Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ACHV

ACHV - Achieve Life Sciences Inc Stock Price, Fair Value and News

$4.36-0.25 (-5.42%)
Market Closed

Price Targets

ACHV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ACHV Price Action

Last 7 days

-19.6%

Last 30 days

-1.8%

Last 90 days

-16.8%

Trailing 12 Months

40.2%

ACHV RSI Chart

ACHV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ACHV Valuation

Market Cap

232.1M

Price/Earnings (Trailing)

-4.44

Price/Sales (Trailing)

49.85

EV/EBITDA

-17.1

Price/Free Cashflow

-5.71

ACHV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

ACHV Fundamentals

ACHV Revenue

Revenue (TTM)

5.1M

ACHV Earnings

Earnings (TTM)

-52.3M

Earnings Growth (Yr)

-15.42%

Earnings Growth (Qtr)

-13.55%

ACHV Profitability

EBT Margin

-323.88%

Return on Equity

-155.67%

Return on Assets

-100.56%

Free Cashflow Yield

-17.53%

ACHV Investor Care

Shares Dilution (1Y)

54.80%

Diluted EPS (TTM)

-1.38

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
201619.7M17.8M11.1M5.1M
201516.8M15.9M17.8M18.2M
201436.5M35.1M30.1M27.1M
201323.9M27.8M31.1M29.9M
20125.6M6.2M11.6M20.1M
201110.1M10.3M6.6M5.5M
2010021.6M17.6M13.6M
200900025.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Achieve Life Sciences Inc

ACHV
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.
 CEO
 WEBSITEachievelifesciences.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES20

Achieve Life Sciences Inc Frequently Asked Questions

ACHV is the stock ticker symbol of Achieve Life Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Achieve Life Sciences Inc is 232.1 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ACHV's fair value in chart for subscribers.

The fair value guage provides a quick view whether ACHV is over valued or under valued. Whether Achieve Life Sciences Inc is cheap or expensive depends on the assumptions which impact Achieve Life Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACHV.

As of Wed Jan 28 2026, ACHV's PE ratio (Price to Earnings) is -4.44 and Price to Sales (PS) ratio is 49.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACHV PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Achieve Life Sciences Inc has provided -0.441 (multiply by 100 for percentage) rate of return.